PAM
ONCE

Paradigm Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Paradigm Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,500
Closed -$388K – 558
2017
Q2 		$388K Sell
6,500
-6,700
-51% -$374K 0.08% 263
2017
Q1 		$704K Buy
+13,200
New +$784K 0.13% 180

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Paradigm Asset Management's ONCE Position: Q3 2017 in Review

Paradigm Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2017, closing a stake of 6,500 shares — an estimated $388K sold.

Paradigm Asset Management first reported a position in ONCE in Q1 2017 and held it in 2 quarters. The position peaked at $704K in Q1 2017. 163 funds tracked by Wall St. Rank hold ONCE as of Q3 2017.

  • Paradigm Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 6,500 Spark Therapeutics, Inc. Common Stock shares in Q3 2017, an estimated $388K.
  • Paradigm Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Paradigm Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $704K in Q1 2017.
  • 163 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.